Non-culprit Vessels for ST-Segment Elevation Myocardial Infarction

NCT02154919 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 306

Last updated 2014-06-03

No results posted yet for this study

Summary

To compare the different effect of conservative pharmacotherapy and Staged Percutaneous Coronary Intervention (SPCI) on significant non-culprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) at presentation remains controversial

Conditions

  • Conservative Pharmacotherapy
  • Staged Percutaneous Coronary Intervention
  • Non-culprit Vessels
  • ST-Segment Elevation Myocardial Infarction

Interventions

PROCEDURE

Percutaneous coronary intervention

Sponsors & Collaborators

  • Beijing Shijitan Hospital, Capital Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2013-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02154919 on ClinicalTrials.gov